Risk Factors and Pathogenic Mechanism for Secondary Primary Lung Cancer
in Breast Cancer Patients: A Review.
10.3779/j.issn.1009-3419.2022.101.46
- Author:
Di CHEN
1
;
Yaolai XIAO
2
;
Kaize ZHONG
3
Author Information
1. Clinical College of Jining Medical University, Jining 272000, China.
2. Department of Respiratory and Critical Care Medicine, Jining No.1 People's Hospital, Jining 272000, China.
3. Department of Thoracic Surgery, Jining No.1 People's Hospital, Jining 272000, China.
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Risk factors;
Second primary lung cancer
- MeSH:
Humans;
Female;
Lung Neoplasms/pathology*;
Carcinoma, Non-Small-Cell Lung/pathology*;
Breast Neoplasms/complications*;
Neoplasms, Second Primary/pathology*;
Risk Factors
- From:
Chinese Journal of Lung Cancer
2022;25(10):750-755
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer and lung cancer are the two most common malignancies in China. With the continuous improvement of breast cancer diagnosis and treatment technology, the survival time of breast cancer patients has been prolonged, and the number of breast cancer patients with second primary lung cancer (SPLC) has increased. In addition, breast cancer is the most common primary cancer in female patients with SPLC, and SPLC is the main cause of death in this population. More and more physicians pay attention to this clinical phenomenon. This paper summarized the risk and risk factors of SPLC in breast cancer patients, and elaborated its pathogenesis, in order to provide a theoretical basis for the clinical management of breast cancer patients and achieve accurate early intervention as soon as possible.
.
